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Abstract
Background: Vector-borne diseases (VBDs) impact both human and veterinary medicine and pose special public
health challenges. The main bacterial vector-borne pathogens (VBPs) of importance in veterinary medicine include
Anaplasma spp., Bartonella spp., Ehrlichia spp., and Spotted Fever Group Rickettsia. Taxon-targeted PCR assays are
the current gold standard for VBP diagnostics but limitations on the detection of genetically diverse organisms
support a novel approach for broader detection of VBPs. We present a methodology for genetic characterization of
VBPs using Next-Generation Sequencing (NGS) and computational approaches. A major advantage of NGS is the
ability to detect multiple organisms present in the same clinical sample in an unsupervised (i.e. non-targeted) and
semi-quantitative way. The Standard Operating Procedure (SOP) presented here combines industry-standard
microbiome analysis tools with our ad-hoc bioinformatic scripts to form a complete analysis pipeline accessible to
veterinary scientists and freely available for download and use at https://github.com/eltonjrv/microbiome.westernu/
tree/SOP.
Results: We tested and validated our SOP by mimicking single, double, and triple infections in genomic canine
DNA using serial dilutions of plasmids containing the entire 16 S rRNA gene sequence of (A) phagocytophilum, (B) v.
berkhoffii, and E. canis. NGS with broad-range 16 S rRNA primers followed by our bioinformatics SOP was capable of
detecting these pathogens in biological replicates of different dilutions. These results illustrate the ability of NGS to
detect and genetically characterize multi-infections with different amounts of pathogens in a single sample.
Conclusions: Bloodborne microbiomics & metagenomics approaches may help expand the molecular diagnostic
toolbox in veterinary and human medicine. In this paper, we present both in vitro and in silico detailed protocols
that can be combined into a single workflow that may provide a significant improvement in VBP diagnostics and
also facilitate future applications of microbiome research in veterinary medicine.
Keywords: Vector-borne diseases, vector-borne pathogens, blood microbiome, diagnostics, NGS, 16S rRNA,
computational pipeline
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Background
Vector-borne diseases (VBDs) impact both human and
veterinary medicine and pose special public health chal-
lenges. According to the One Health concept, animal
health, environmental health, and human health are all
interrelated [1]. In fact, 60 % of all human infectious dis-
eases are classified as zoonotic diseases, having an ani-
mal origin [2]. The World Health Organization (WHO)
reports that vector-borne diseases (VBD) represent more
than 17 % of all known infectious diseases worldwide,
causing over 700,000 annual deaths with billions of
people at risk of contracting a VBD in 129 countries [3].
Data from the World Organization for Animal Health
(OIE) shows that 25 % of terrestrial vertebrate pathogens
of concern are vector-borne [4]. Also, the Companion
Vector-borne Diseases Organization (CVBD) highlights
that in more than half of the continental regions in the
world, companion animals are threatened by three or
more endemic VBDs [5]. Pathogen-harboring arthropods
(also called vectors) such as mosquitoes, sandflies, fleas,
and ticks are natural conduits for microorganisms to in-
fect their vertebrate hosts. These complex host-pathogen
relationships are constantly remodeled by environmental
conditions including anthropogenic influences such as
global climate change, urbanization, economic
globalization, and pesticide use [6, 7]. Such phenomena
increase the risk of infection of non-reservoir mamma-
lian hosts (e.g. humans and domestic animals), which
are also called incidental hosts. VBD research is there-
fore strategically important to maintain and improve
public health.
Vector-borne pathogens (VBPs) encompass a wide
variety of organisms distributed among different phylo-
genetic groups. In recent years, the advent and increas-
ing adoption of Next-Generation Sequencing (NGS) and
associated bioinformatics have dramatically increased
our understanding of the complexity and importance of
bacterial communities in a variety of environmental and
clinical samples [8, 9]. For example, the Human Micro-
biome Project (HMP), a research consortium that started
over a decade ago, has used NGS to investigate the com-
position and function of microbial communities in over
40 different body sites on > 30,000 samples [10]. Typic-
ally, microbiome research has been descriptive, often
comparing healthy and diseased communities, consider-
ing the whole microbiota [11, 12]. As sequencing costs
have continued to decline, more specific applications
have become feasible such as identifying etiologic agents
of disease in clinical samples for diagnostics and public
health surveillance [13].
Several recent studies have characterized the microbial
communities of arthropod vectors and their role in VBD
transmission [14–18]. In our work, we have utilized 16 S
rRNA NGS to characterize the microbiome and the
presence of VBPs in cat fleas (Ctenocephalides felis) from
Northern and Southern California [19]. Such approaches
are increasingly being adopted in Veterinary Medicine,
especially for the characterization of the blood micro-
biome of companion animals. For example, using NSG
targeting the 16 S rRNA of the 18 S rRNA genes, high
rates of Anaplasma platys, Babesia vogeli, Ehrlichia
canis, Hepatozoon canis, and hemotropic Mycoplasma
infection and co-infection were reported from a popula-
tion of temple dogs in Thailand, where the NGS assay
was reported to be more sensitive than conventional
endpoint PCR diagnostic methods [20, 21]. Furthermore,
optimizations in the amplification of bacterial DNA by
using host-specific blocking primers combined with op-
timal DNA extraction prior to NGS further improved
the sensitivity and diversity of canine VBPs in one study
[22]. The use of microbiomics or metagenomics strat-
egies for the detection and characterization of VBPs is
poised to expand and benefit not only veterinary re-
searchers but also clinicians in the near future.
NGS can be performed on any sample of interest by
either direct sequencing with no PCR amplification of
DNA (metagenomics) or RNA (metatranscriptomics) or
targeting an amplicon, such as the 16 S rRNA gene
(16 S-NGS) for prokaryotes or the 18 S rRNA gene for
eukaryotes, which have become gold-standard marker
genes for phylogeny and large-scale microbiome com-
parisons of bacterial and protozoan microorganisms.
Several NGS workflows for infectious diseases already
exist [13, 23], including recently published specialized
methods targeting either 16 S rRNA or 18 S rRNA genes
for canine VBPs comprising either bacteria or protozoa
(apicomplexan piroplasms and/or euglenozoan kineto-
plastids haemoparasites) [20, 21]. A need remains for a
detailed step-by-step data analysis protocol for VBPs in
the NGS diagnostic landscape for use by non-
bioinformaticians, especially in veterinary medicine.
The goal of the current article is to describe a Stand-
ard Operating Procedures (SOP) for microbiome ana-
lyses targeting VBPs of importance in companion
animals. We tested the proposed bioinformatic workflow
usingin-vitro data from selected VBPs. We focus exclu-
sively on the 16 S-NGS approach due to its experimental
affordability for diagnostics purposes and relatively
straightforward computational requirements. Also, we
determined the ability of NGS to detect simulated co-
infections or multi-infections with VBPs. Our in- silico
veterinary-focused microbiome methods adopt freely
available industry-standard tools for 16 S-NGS analyses,
adapting and executing pipelines from the QIIME [24]
and Uparse [25] software packages. The computational
SOP is available at https://github.com/eltonjrv/
microbiome.westernu/tree/SOP and combines these
existing software tools with our BASH, PERL, and R
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scripts to form a complete analysis pipeline accessible to
veterinary scientists. To our knowledge, this is the first
release of a detailed SOP for microbiome analyses ap-
plied to VBD diagnostics available free of copyright to
the Veterinary Medicine community.
Results
16 S-NGS Computational Workflow
Next-generation sequencing significantly advances the
field of clinical microbiology by generating millions of
individual DNA sequence reads from a single sample
that allows for a comprehensive evaluation of bacterial
diversity that is not subject to typical limitations of
culture-based approaches. A schematic microbiomics
computational workflow, typically 16 S-NGS, is depicted
in Fig. 1. Once followed by the in vitro protocol we de-
scribe in the Methods section, it can be adopted in the
small animal diagnostics field, for instance.
Once sequenced, the library must pass through a bio-
informatics pipeline that performs demultiplexing, qual-
ity control, error correction, operational taxonomic unit
(OTU) clustering, and identification, and may include
subsequent statistical hypothesis tests regarding treat-
ment effects, etc. For the current study focused on de-
tection and characterization of bloodborne pathogens,
characterizations of the phylogenetic diversity of taxa of
interest (ToI) were particularly important (Fig. 1 and
SOP GitHub page disclosed herein). Comprehensive
microbiome analysis typically focuses on comparing
sample sets (e.g. non-infected vs. infected animals)
through statistical comparisons of beta-diversity, using
distance matrices (e.g. bray_curtis, jaccard) produced
from the microbiome compositional data sets. Pairwise
phylogenetic distances between samples can be com-
pared using industry-standard tools like Unifrac [26] to
test for significant phylogenetic differences between or
among groups. Finally, a variety of data visualization ap-
proaches are commonly used such as principal coordin-
ate analysis (PCoA) charts, along with the regular taxa
relative abundance bar plots (Fig. 2).
Currently in veterinary medicine, the limited broad-
range evaluation of clinical samples may restrict the de-
tection of new and emerging zoonotic diseases. 16 S-
NGS can circumvent this limitation by broad-range
amplification of the whole bacterial community in a
sample and can discriminate among amplicons at a
single-nucleotide resolution. Phylogenetic analysis of se-
quence types representing putative pathogens in clinical
samples is also crucial for identifying new VBD etiologic
agents. Our bioinformatics SOP also provides instruc-
tions on these types of analysis and will help non-expert
users to extract valuable information on potential novel
pathogenic bacterial species and/or strains that might be
hidden in their clinical microbiome dataset. Once gener-
ated, so-called “zero-radius operational taxonomic units”
(ZOTUs), also known as “exact sequence variants”
(ESVs) - which are 100 % identical 16 S amplicon se-
quences identified among the tens to hundreds of
Fig. 1 Schematic computational workflow for microbiome analysis
that can be applied to VBDs diagnostics in Veterinary Medicine. See
the Methods section for details
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millions of reads from all samples (see SOP subtopic 2.2
for technical details) – can be classified by comparison
against 16 S rRNA sequences from known pathogens
using a phylogenetic inference approach (See SOP topic
4 for technical details). Of course, one must perform this
comparison against a reliable and comprehensive 16 S
database. We recommend the SILVA database [27]
loaded within the ARB environment [28] for such a task.
Detecting single and multi-infections with 16 S-NGS
The efficiency of the NGS platform involving 16 S rRNA
amplicon sequencing in detecting known amounts of
bacteria was verified by performing quality controls
using standard microbial communities (ZymoBIOMICS™
Microbial DNA Community Standard, CA). The mock
community standards consist of eight prokaryotic genera
in different proportions for 16 S rRNA genes in one
sample. The community standards were amplified using
the primer pairs for the V1-V2, V3-V4, and V4-V5 re-
gions of the 16 S rRNA gene and sequenced with other
samples in the same MiSeq run (see Methods section).
We analyzed the amplicon data for the mock commu-
nity with our newly developed pipeline. We were able to
successfully detect all eight prokaryotic genera from the
mock community standards and the relative abundance
of most of the eight genera closely matched the theoret-
ical composition expected for the V1-V2 and V3-V4 re-
gions. Interestingly, for the V4-V5 region, only five out
of the eight genera were detected (Fig. 2).
As demonstrated by Tables 1 and 2, one of the pri-
mary advantages of NGS is its ability to detect single
and multiple organisms present in the same sample. We
Fig. 2 Comparison of the detection accuracy of the workflow using one of the Microbial Community Standard available with ZymoBIOMICS™.
Three different variable regions; i.e. V1-V2, V3-V4, and V4-V5, of the 16 S rRNA gene were amplified in quadruplicate and analyzed. The X-axis
represents the groups compared; The Y-axis represents the abundance of the microbial genera in the sample
Table 1 Summary of detection of the positive controls in the corresponding dilution for single-infection of six vector-borne
pathogens. Numbers in the first bracket represent the number of times it was detected out of the number of times it was tested.
Each sample was amplified for three variable regions of the 16S rRNA gene; V1-V2, V3-V4, and V4-V5
Single Infection
Vector-borne pathogen 106 105 104 103 102 101
A. phagocytophilum Yes(2/4) Yes(2/4) Yes(2/4) Yes(2/4) Yes(1/4) Yes(1/4)
B. henselae Yes(4/4) Yes(4/4) Yes(4/4) Yes(4/4) Yes(1/4) No(0/4)
B. vinsonii subsp. berkhoffii Yes(4/4) Yes(4/4) Yes(4/4) Yes(3/4) Yes(2/4) No(0/4)
E. canis Yes(4/4) Yes(4/4) Yes(4/4) Yes(4/4) Yes(3/4) Yes(2/4)
E. chaffeensis Yes(4/4) Yes(4/4) Yes(8/8) Yes(8/8) Yes(8/8) Yes(1/4)
M. haemocanis Yes(4/4) Yes(4/4) Yes(4/4) Yes(4/4) Yes(2/4) No(0/4)
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considered a positive detection for any sample when the
taxa of interest were detected at least once out of the mul-
tiple sequencing efforts. For single-infection controls, out
of the six pathogens tested in six different dilutions (101-
106), all of them were consistently detected down to the
102 dilution (Table 1). Two Bartonella spp. and M. hae-
mocanis were not detected in the 101 dilutions out of the
4 trials (Table 1). For both double and triple-infections,
similarly, consistent detection was obtained (Table 2). In
general, 102 was the minimum threshold of detection for
the assays tested here (Tables 1 and 2).
Discussion
The introduction of PCR-based assays in the early 90 s
led to a substantial improvement in the diagnostics of
canine vector-borne diseases. However, in light of the
increasing number of new tick-borne pathogens detected
from dogs and humans, such as Panola Mountain Ehrli-
chia sp. [29, 30], E. muris [31, 32], and several new Bar-
tonella spp. [33–35], VBP diagnostics may benefit from
the ability of high-throughput DNA sequencing assays
to detect a broader range of microbial DNA from a
given sample.
Next-generation sequencing (NGS) is based on mas-
sively parallel sequencing of billions of nucleotide reads,
covering the same targeted region up to 1000 times, with
each read classified independently. Consequently, the
identification of all sequence variants of the targeted
area can be performed. NGS targeting 16 S rRNA genes
was initially used to characterize environmental samples
but has expanded into diagnostics in recent years [36,
37]. In two studies in ticks, NGS was able to identify the
presence of novel canine and human pathogens such as
Neoehrlichia mikurensis as well as co-infections with
Ehrlichia and Anaplasma [38, 39], and Bartonella sp.
and Rickettsia sp. were detected from fleas [19]. More
recently, NGS was used to detect the presence of several
VBPs including bacteria and protozoans, in single and
co-infection, from dogs naturally infected in Thailand
[20, 21], illustrating the capabilities of NGS as a molecu-
lar diagnosticmethod.
While PCR-based assays remain the current gold-
standard for molecular diagnostics of vector-borne path-
ogens, the use of NGS is rapidly expanding due to ad-
vantages such as: detection of unknown disease-
associated pathogens in clinical specimens,
characterization of co-infections, investigation of micro-
bial population diversity in the host, and strain
characterization [43]. Nonetheless, there are several bar-
riers to the broader use of NGS in molecular diagnostics,
including but not limited to: carryover microbial DNA
contaminants from sample collection tools and lab re-
agents, sequencing error rates, elevated cost, result turn-
over time, analytical sensitivity, and preferential
amplification of dominant microbial sequences [40, 41].
As demonstrated in Fig. 2, different sets of primers tar-
geting distinct variable regions of the 16 S rRNA gene
may yield different results regarding the relative abun-
dance of microbial communities. Also, the analytical
sensitivity and limit of detection (LOD) achieved by the
16 S NGS assays performed in this study remain sub-
optimal when compared to the LOD reached by our
conventional or real-time PCR assays for some of these
pathogens [42, 43]. Other research groups have reported
NGS sensitivity to canine VBPs comparable or even su-
perior to conventional endpoint PCR [20, 21] The tar-
geting of the 16 S rRNA gene has also limited capability
in defining species within genera where this region is
highly conserved, such as Rickettsia spp. and Brucella
spp. Future advances in NGS technology such as longer
Table 2 Summary of detection of the positive controls in the
corresponding dilution for co-infections of six vector-borne
pathogens. Numbers in the first bracket represent the number
of times it was detected out of the number of times it was
tested. Each sample was amplified for three variable regions of
the 16S rRNA gene; V1-V2, V3-V4, and V4-V5
Double Infection
A. phagocytophilum plus E. canis
Vector-borne
pathogen
106:106 105:106 104:106 103:106 102:106
A. phagocytophilum Yes(4/4) Yes(4/4) Yes(4/4) Yes(2/4) No(0/4)
E. canis Yes(4/4) Yes(4/4) Yes(4/4) Yes(4/4) Yes(4/4)




A. phagocytophilum Yes(4/4) Yes(4/4) Yes(4/4)
B. henselae Yes(4/4) Yes(4/4) Yes(4/4)
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read lengths are expected to address some of these limi-
tations, making it a potentially transformative tool for
the diagnosis of new or emerging pathogens in animals
and humans.
In this methodology article, we disclosed both bench-
top protocols and a “step-by-step” bioinformatics tutor-
ial for performing microbiome assays and analyses,
respectively, on VBD diagnostics in Veterinary Medicine.
While in this article we only report the results from syn-
thetic positive controls, we have successfully used this
bioinformatic pipeline to detect the presence of Ana-
plasma phagocytophilum or Ehrlichia ewingii in dog
blood [44].
Conclusions
The detailed 16 S-NGS protocols for microbiome ana-
lyses provided herein can efficiently and accurately
characterize mock communities and may also be able to
detect co- and multi-infections of VBPs. These proce-
dures can be combined into a single workflow that
should facilitate future applications of microbiome ap-
proaches to VBD diagnostics in Veterinary Medicine.
Such approaches may improve current understandings
of VBDs and their impact on both Veterinary and Hu-
man Medicine.
Methods
Positive controls and standard curves
Synthesis of positive controls and generation of standard
curves were completed by cloning full 16S rRNA se-
quences of Anaplasma phagocytophilum, Ehrlichia canis,
E. chaffeensis, B. henselae, Bartonella vinsonii berkhoffii
(B.v.b), and Mycoplasma haemocanis into plasmids
(Eurofins Genomics LLC, Louisville, KY, USA). A. pha-
gocytophilum positive control was generated from the
consensus sequence derived after careful analysis of the
16S rRNA sequence alignment associated with the fol-
lowing accession numbers; CP006618, CP006616,
APHH01000002, NC_007797, and CP006617. Similarly,
for E. canis, a consensus sequence of strains Jake
(CP000107), Oklahoma (NR_118741), Florida (M73226),
and Malaysia (KR920044) was synthesized. For E. chaf-
feensis, strain Arkansas (NC_007799) was used. For B.
henselae strain Houston-1 (CP020742) was used as a
positive control whereas for B. vinsonii berkhoffii Winnie
(CP003124) was used. Lastly M. haemocanis Illinois
(CP003199) was used as a reference to generate the posi-
tive control. Standardized ten-fold dilutions were then
generated for each plasmid from 1 × 107 to 0.1 copies
per microliter (µL). The dilutions were made with dog
gDNA to simulate natural infection. The gDNA concen-
tration from this dog was quantified by spectrophotom-
etry (average concentration of 27.8 ± 1.1 ng/dL with
average 260/280 ratio of 1.88 ± 0.05) and the absence of
PCR inhibitors was demonstrated by amplification of a
fragment of the glyceraldehyde-3-phosphate dehydro-
genase gene, as described previously [45]. Positive sam-
ples were diluted using VBP free EDTA-whole blood,
confirmed using the molecular vector-borne disease
panel from Vector-Borne Disease Diagnostic Laboratory
at North Carolina State University College of Veterinary
Medicine which tests for the following genera: Ana-
plasma, Babesia, Bartonella, Ehrlichia, Hemotropic
Mycoplasma, Spotted-Fever Rickettsia, and Leishmania
[46–49]. A different modified forward primer AE16S_
45F (5’ AGCYTAACACATGCAAGTCGAACG3’) was
used to detect Anaplasma and Ehrlichia [48] in the real-
time PCR assay.
NGS library preparation and sequencing
For 16 S rRNA gene regions V1-V2 (~ 350 bp) and V3-
V4 (~ 460 bp), the NGS libraries were created with pro-
prietary primers from Zymo (Zymo Quick-16 S NGS Li-
brary Prep Kit, Zymo Research, Irvine, CA). For the V4-
V5 region, universal primers (~ 550 bp) were used as
previously described [50], followed by a barcoding
scheme based on Faircloth and Glenn [51] as previously
used by our research group [52]. These barcoding tags
have been validated with the EDITTAG algorithm as
previously described [51] and shown to be less error-
prone than earlier barcode designs [53]. Illumina MiSeq
2 × 300 bp v2 kit was used to sequence the library at the
University of Southern California Genome Core Center.
Library preparation quality control
During library preparation, utmost importance was given
to quality control. A biosafety cabinet was used for sam-
ple preparation in separate and dedicated space. As de-
scribed in detail in Oney et al. (44) adequate measures
were taken to prevent barcode cross-contamination. Li-
braries were further purified by magnetic clean-up, were
quantified by automated electrophoresis (BioAnalyzer
2100, Agilent, Santa Clara, CA), and pooled according to
Illumina recommendations [54].
Simulation of co-infection with synthetic plasmids
For single infections all total six different pathogens
were amplified for three different 16 S rRNA variable re-
gions; V1-V2, V3-V4, & V4-V5. Among them (A) phago-
cytophilum, (B) henselae, B. vinsonii subsp. berkhoffii, E.
canis, and M. haemocanis were tested in quadruplicate,
whereas E. chaffeensis was tested eight times. Serial dilu-
tions 1 × 106 through 1 × 101 copies/µL for all six syn-
thetic plasmids were created. To simulate different
possibilities of co-infection, A. phagocytophilum serial
dilutions of 1 × 106 to 1 × 102 were mixed in descending
order of copies per reaction with E. canis which was at a
fixed concentration of 1 × 106 for all reactions. In
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another effort, (A) phagocytophilum serial dilutions of
1 × 104 to 1 × 102 were mixed with (B) henselae at a fixed
concentration of 1 × 104. These conditions were also
used to simulate triple co-infection consisting of (A)
phagocytophilum, E. canis, and (B) vinsonii subsp. ber-
khoffii with E. canis being the standard at 1 × 106 copies
per reaction while (A) phagocytophilum and (B) vinsonii
subsp. berkhoffii were mixed in decreasing order of con-
centration of 1 × 106 to 1 × 102. Similarly, for another
triple infection control fixed dilutions (104) of E. canis
and M. haemocanis were mixed with different dilutions
(1 × 104 to 1 × 102) of B. vinsonii subsp. berkhoffii. All
the double and triple infections were also repeated quad-
ruplicate times or more (Tables 1 and 2).
PCR amplification, barcoding, and amplicon sequencing
Custom dual indexed adapters were used to amplify the
single, double and triple co-infections targeting the V1-
V2 (~ 349 bp), V3-V4 (~ 460 bp), and V4-V5 (~ 410 bp)
regions of the 16 S rRNA gene. The positive control was
the ZymoBIOMICS™ Microbial Community DNA Stand-
ard (Zymo Research, Irvine, CA). Amplification for the
first PCR reaction was performed by conventional PCR
using the Eppendorf Master cycler using single hot start
at 94 °C for 2 min, futher 30 cycles of denaturing at
94 °C, annealing at 57 °C for 45 s, and final extension at
72 °C for 1 min, with the PCR reaction in a 25 µL final
volume containing 10X Ex Taq Buffer, dNTPs, and
Takara Ex Taq HS (Takara Bio Inc., Shiga, Japan), 10
pmol of each primer, 2 µL of DNA template. The second
amplification of 15 cycles was performed with the same
conditions as the first, but with 1 µL of template coming
from the primary inoculation. With 16 S rRNA primers,
the target amplicon was amplified during the first step.
In the second step, i5 and i7 barcoded primers in 96-
well configurations were used to form a library for se-
quencing [51]. Negative controls consisted of molecular-
grade water and gDNA from an uninfected dog used to
prepare the serial dilutions of positive controls, to
characterize any bacterial DNA contaminants from the
PCR reagents, as well as from the gDNA used, respect-
ively. 1.5 % agarose gel electrophoresis with 1kp Plus
DNA Ladder. V4-V5 amplicons were then normalized
according to the manufacturer’s instructions (SequalPrep
Normalization Plate kit, ThermoFisher Scientific, Wal-
tham, MA, USA) and were then pooled into 5mL tubes
and stored at -30 °C. V1-V2 and V3-V4 amplicons were
normalized using the ZymoBIOMICS™ 96 MagBead
DNA Kit (Zymo Research, Irvine, CA, USA) as per the
manufacturer’s protocol. Samples were sequenced with
Illumina MiSeq paired-end V3 sequencing chemistry,
with three to four 96-well plates simultaneously multi-
plexed per run. The number of raw and processed reads
is available in Supplementary Table 1.
Bioinformatics pipeline on Mock samples analysis
Our computational pipeline for 16 S-NGS microbiome
analysis is available in detail as a Standard Operating
Procedure (SOP) publicly available at https://github.
com/eltonjrv/microbiome.westernu/tree/SOP. Besides
detailed ordered steps and useful commented com-
mands, the SOP URL above also provides accessible
links for in-house supporting scripts plus a customized
RDP reference database [55] for a better taxonomic clas-
sification of bacterial VBPs of interest in Veterinary
Medicine (https://github.com/eltonjrv/microbiome.
westernu/tree/refDB). Due to the open-source nature of
most of the adopted programs, the SOP must be run on
a Unix Platform (either Mac or Linux). After installing
the required tools, both Unix-familiar users and novices
will be able to run it without any further difficulties,
since we have provided detailed explanations for each
step of the pipeline.
In brief, the sequence data were initially checked for
barcodes with QIIME v1.9 extract_barcodes.py script
[55], then demultiplexed with the new “qiime demux
emp-paired” function from the QIIME2 package [56].
Primers were removed using Trimmomatic [55]. Uparse
tool was applied using the new -unoise3 function for
modeling and correcting Illumina-sequenced amplicon
errors, including detection and removal of chimeras, as
well as generating operational taxonomic unit (OTU) ta-
bles at a 100 % identity level, also called as ZOTUs
(zero-radius OTUs) or ESVs (Exact Sequence Variant)
(please refer to our ad hoc Uparse bash script available
at https://github.com/eltonjrv/microbiome.westernu/
blob/master/run-uparse-amp250-450-ZOTUs.bash). In
addition to the ZOTUs, we have also provided an advan-
tageous feature from Usearch regarding OTU clustering
at 95 %, 97 %, and 99 % identity levels for comparison
purposes (https://github.com/eltonjrv/microbiome.
westernu/blob/master/run-uparse-amp250-450-
OTUs95_97_99_100.bash). Users may want to have the
flexibility to work downstream with any relevant per-
centage of identity threshold that suits their data.
Background abundance of microbial taxa is a major
hindrance for accurate analysis of low diversity samples.
The background diversity is expected to be present in
every sample and our previous data and other studies
have shown that the frequency of contamination is dir-
ectly related to the sample DNA abundance within total
DNA content [44, 57, 58]. Along with the existing tools
to remove such contamination from the sample [57–59],
we have provided two new options in our pipeline to
deal with such background contaminations in the data-
set: (1) An ad-hoc R script was written for subtracting
negative control-derived ZOTU counts from target sam-
ples (see SOP step 3.2.1). The use of blank negative con-
trol(s) with no sample DNA is of utmost importance for
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the analysis of low diversity samples. Users shall analyze
the blank sets as negative-control samples (with no ex-
ternally supplied DNA) and generate ZOTUs/OTUs
using the same parameters as individual samples. After-
ward, using the first utility users can remove the abun-
dance present in the negative control from the actual
samples at ZOTU/OTU level. In addition to removing
the background diversity, this particular option has its
usefulness in dealing with cross-contamination as well.
In the latter case, if cross-contamination occurs during
the sample preparation step from the actual sample to
the blank negative control, during negative control re-
moval it will not remove the ZOTU/OTU completely
from the sample. The abundance of contaminant
ZOTU/OTU in the blank control set theoretically can-
not surpass the abundance of that particular ZOTU/
OTU in the actual sample. (2) An alternative ad hoc
PERL code is provided for removing the whole ZOTUs/
OTUs content present in negative controls from the ac-
tual samples to be assessed. Through that PERL code,
users can remove the whole negative control-derived
ZOTUs/OTUs content from their target samples, rather
than count subtraction (see SOP steps 3.2.2 and 3.2.3).
After generating ZOTUs/OTUs from the blank controls
like earlier, this option will match every ZOTU/OTU
present in the control to the sample ZOTUs/OTUs and
remove them from the latter. Though this option can be
equally effective while dealing with contaminations from
background negative controls to the samples, users need
to be cautious for the cross-contamination that may
happen during the sample preparation step from actual
samples to the negative controls.
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